Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Dr. Reddy's Laboratories Ltd. ADR buy Barclays PLC

Start price
€64.00
29.01.24 / 50%
Target price
€73.92
29.01.25
Performance (%)
7.81%
Price
€69.00
26.04.24
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 7.81%. This prediction currently runs until 29.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Dr. Reddy's Laboratories Ltd. ADR 3.788% 3.788%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Barclays_PLC for this prediction

In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren
Prediction Buy
Perf. (%) 7.81%
Target price 73.920
Change
Ends at 29.01.25

Dr. Reddy's Laboratories Limited (NYSE: RDY) had its price target raised by analysts at Barclays PLC from $75.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for RDY provided by MarketBeat